BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26463718)

  • 1. High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma.
    Lv D; Yang H; Wang W; Xie Y; Hu W; Ye M; Chen X
    BMC Cancer; 2015 Oct; 15():687. PubMed ID: 26463718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.
    Zhang J; Wang JC; Li YH; Wang RX; Fan XM
    Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
    Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
    Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
    Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
    Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.
    Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T
    Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells.
    Smith AJ; Wen YA; Stevens PD; Liu J; Wang C; Gao T
    Oncotarget; 2016 Feb; 7(7):7801-15. PubMed ID: 26760962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
    Rajala RV; Kanan Y; Anderson RE
    Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High PHLPP1 expression levels predicts longer time of acquired resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma.
    Xie Y; Lv D; Wang W; Ye M; Chen X; Yang H
    Oncotarget; 2017 Aug; 8(35):59000-59007. PubMed ID: 28938613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
    Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
    Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
    Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
    Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
    Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
    Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).
    Shimoji M; Shimizu S; Sato K; Suda K; Kobayashi Y; Tomizawa K; Takemoto T; Mitsudomi T
    Lung Cancer; 2016 Aug; 98():69-75. PubMed ID: 27393509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
    Wu Y; Huang B; Liu Q; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.